Open original FDA record ↗Recall record
- FDA identifier
- Z-2323-2021
- Company in FDA record
- Cytocell Ltd.
- FDA record creation date
- Aug 18, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
May show unexpected locus specific signals in addition to those at 19p13.3. Users may observe faint additional locus specific signals at 9q34
Source facts
- Action
- Cytocell issued Urgent Medical Device Recall Users issued via email on 5/27/21. Letter states reason for recall, heath risk and action to take: Immediately examine your inventory and quarantine all product subject to recall. Cytocell requests that you destroy the remaining inventory. We also suggest that laboratories undertake a review any results obtained with the affected devices and check that signal patterns were not misinterpreted as a result of any additional locus specific signal at 9q34. If you have any questions, contact Cytocell on Tel: +44 (0)1223 294048, Fax +44(0)1223 294986 or vigilance@ogt.com.
- Initiated
- 2021-05-27
- Root cause
- Nonconforming Material/Component
- Terminated
- 2022-05-09
- Distribution
- US Nationwide distribution in the states of CA, IL, KY, NY, OH, TX, UT, VA.
- Recall number
- Z-2323-2021
- Recall status
- Terminated
- CDRH record ID
- 188305
- FDA record created
- 2021-08-18
- Recall event number
- 88294